---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-062509"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2026-05-15T20:06:16+00:00"
generated_at: "2026-05-15T20:12:49.729399+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Profound Medical 2026 AGM: All director nominees elected; incentive plan approved with 36% against

## Summary
- Arthur Rosenthal re-elected with 79.0% for vs 21.0% withheld; lowest support among eight nominees.
- Unallocated RSUs/DSUs under LTIP approved: 63.9% for, 36.1% against.
- PricewaterhouseCoopers LLP reappointed as auditor with 99.5% for.
- Total shares outstanding 36,337,637 as of April 2, 2026 record date.

## SEC filing metadata
- accession: 0001104659-26-062509
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2026-05-15T20:06:16+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000110465926062509/0001104659-26-062509-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000110465926062509/tm2614840-1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-062509
- JSON: https://secwatch.observer/filing/0001104659-26-062509.json
- Plain text: https://secwatch.observer/filing/0001104659-26-062509.txt

## Key facts
- Shareholder Votes
  Profound Medical Corp. shareholders approved Election of eight director nominees to serve until the next annual meeting at the 2026-05-13 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-05-13
  source text: Each of the eight nominees listed below was elected as director of the Company to hold office until the Company's next annual meeting of shareholders or until their successor is duly appointed.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628808/000110465926062509/0001104659-26-062509-index.htm
- Shareholder Votes
  Profound Medical Corp. shareholders approved Ordinary resolution approving all unallocated restricted share units and deferred share units under the Company's long-term incentive plan at the 2026-05-13 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-05-13
  source text: The shareholders approved an ordinary resolution approving all unallocated restricted share units and deferred share units under the Company's long-term incentive plan.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628808/000110465926062509/0001104659-26-062509-index.htm
- Shareholder Votes
  Profound Medical Corp. shareholders approved Appointment of PricewaterhouseCoopers LLP as auditors of the Company until the close of the next annual meeting at the 2026-05-13 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-05-13
  source text: The shareholders approved the appointment of PricewaterhouseCoopers LLP as auditors of the Company until the close of the Company's next annual meeting of shareholders at such remuneration to be fixed by the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628808/000110465926062509/0001104659-26-062509-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.